---
schema_version: "secwatch.filing_event.v1"
accession: "0000875045-26-000039"
form_type: "8-K"
ticker: "BIIB"
cik: "0000875045"
company_name: "BIOGEN INC."
filed_at: "2026-04-06T23:59:59+00:00"
generated_at: "2026-05-15T07:29:20.703847+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Biogen warns of $34M pre-tax IPR&D and upfront charge in Q1 2026, impacting EPS by $0.19

## Summary
- Preliminary estimate: ~$34M pre-tax acquired in-process R&D, upfront and milestone expense for Q1 2026.
- Expected to reduce GAAP and non-GAAP diluted EPS by approximately $0.19 per share.
- Expense includes upfront/milestone payments and premiums on equity securities related to collaboration and license agreements.
- Biogen does not forecast such costs due to uncertainty; final Q1 results not yet finalized and may differ.

## SEC filing metadata
- accession: 0000875045-26-000039
- form_type: 8-K
- ticker: BIIB
- cik: 0000875045
- company_name: BIOGEN INC.
- filed_at: 2026-04-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875045/000087504526000039/0000875045-26-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875045/000087504526000039/biib-20260406.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000875045-26-000039
- JSON: https://secwatch.observer/filing/0000875045-26-000039.json
- Plain text: https://secwatch.observer/filing/0000875045-26-000039.txt

## Key facts
- Earnings Releases
  BIOGEN INC. reported preliminary financial results for the first quarter of 2026.
  - Period: the first quarter of 2026
  - Result: preliminary results
  source text: Biogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the first quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $34 million on a pre-tax basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/875045/000087504526000039/0000875045-26-000039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.